TIAA CREF Investment Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2019
Q1 | $1.52M | Buy |
326,593
+13,489
| +4% | +$62.6K | ﹤0.01% | 2135 |
|
2018
Q4 | $1.32M | Hold |
313,104
| – | – | ﹤0.01% | 2177 |
|
2018
Q3 | $1.96M | Sell |
313,104
-132,883
| -30% | -$833K | ﹤0.01% | 2127 |
|
2018
Q2 | $3.59M | Buy |
445,987
+116,450
| +35% | +$936K | ﹤0.01% | 1838 |
|
2018
Q1 | $2.46M | Sell |
329,537
-6,046
| -2% | -$45.1K | ﹤0.01% | 2002 |
|
2017
Q4 | $2M | Sell |
335,583
-138,301
| -29% | -$823K | ﹤0.01% | 2135 |
|
2017
Q3 | $3.49M | Buy |
473,884
+190,906
| +67% | +$1.41M | ﹤0.01% | 1846 |
|
2017
Q2 | $1.92M | Buy |
282,978
+91,437
| +48% | +$621K | ﹤0.01% | 2208 |
|
2017
Q1 | $1.81M | Sell |
191,541
-10,897
| -5% | -$103K | ﹤0.01% | 2197 |
|
2016
Q4 | $1.75M | Sell |
202,438
-87,518
| -30% | -$756K | ﹤0.01% | 2252 |
|
2016
Q3 | $1.84K | Buy |
289,956
+29,984
| +12% | +$190 | ﹤0.01% | 2225 |
|
2016
Q2 | $1.1M | Buy |
259,972
+44,797
| +21% | +$189K | ﹤0.01% | 2462 |
|
2016
Q1 | $938K | Sell |
215,175
-11,225
| -5% | -$48.9K | ﹤0.01% | 2509 |
|
2015
Q4 | $1.39M | Sell |
226,400
-23,449
| -9% | -$144K | ﹤0.01% | 2374 |
|
2015
Q3 | $1.43M | Buy |
249,849
+8,609
| +4% | +$49.2K | ﹤0.01% | 2353 |
|
2015
Q2 | $1.8M | Sell |
241,240
-34,008
| -12% | -$254K | ﹤0.01% | 2370 |
|
2015
Q1 | $1.65M | Buy |
275,248
+6,608
| +2% | +$39.5K | ﹤0.01% | 2341 |
|
2014
Q4 | $2.03M | Sell |
268,640
-26,284
| -9% | -$199K | ﹤0.01% | 2219 |
|
2014
Q3 | $1.53M | Sell |
294,924
-9,577
| -3% | -$49.7K | ﹤0.01% | 2389 |
|
2014
Q2 | $1.31M | Buy |
304,501
+79,505
| +35% | +$343K | ﹤0.01% | 2558 |
|
2014
Q1 | $920K | Sell |
224,996
-6,800
| -3% | -$27.8K | ﹤0.01% | 2685 |
|
2013
Q4 | $1.24M | Hold |
231,796
| – | – | ﹤0.01% | 2548 |
|
2013
Q3 | $1.17M | Buy |
231,796
+41,737
| +22% | +$210K | ﹤0.01% | 2529 |
|
2013
Q2 | $848K | Buy |
+190,059
| New | +$848K | ﹤0.01% | 2672 |
|